CVS Health Corporation (CVS)
CVS Health Jumps On Q4 Earnings Beat, But Downgrading To Hold
Despite a >10% rise in CVS Health's stock price from my initial BUY recommendation, CVS Health is downgraded to Hold due to substantial political risks and declining cash flow. CVS faces significant challenges, including DOJ lawsuits, potential business separation, political scrutiny, and declining cash flow, impacting its turnaround prospects. CVS reported strong Q4 sales and new leadership from the new CEO David Joyner may bode well for shareholders.
S&P 500 Gains and Losses Today: CVS Stock Jumps as Pharmacy Segment Delivers Growth
Major U.S. equities indexes were mixed on Wednesday as the latest Consumer Price Index (CPI) data showed an unexpected uptick in inflation during January.
CVS CEO defends pharmacy middlemen, accuses drugmakers of 'monopolistic' practices
CVS Health CEO David Joyner defended controversial pharmacy middlemen, who are widely accused of inflating prescription medication prices, and instead accused manufacturers of "monopolistic" practices that keep drug costs high in the U.S. Joyner, who stepped into the role in October, spent much of his opening remarks on the company's fourth-quarter earnings call discussing so-called pharmacy benefit managers, or PBMs.
CVS shares move higher on upbeat Q4 report
CVS Health Corp (NYSE:CVS)'s shares surged more than 15% after the pharmacy chain posted positive financial results for the fourth quarter. Adjusted earnings per share of $1.19 on revenue of $97.71 billion topped analyst expectations of EPS of $0.91 on revenue of $96.89 billion.
Why CVS Health Stock Popped Today
Shares of CVS Health (CVS 13.66%) were soaring Wednesday after the diversified healthcare giant's fourth-quarter results topped estimates and management offered better-than-expected guidance for 2025.
CVS Beats EPS Estimates, Losses Loom
CVS Health (CVS 13.34%), a leading integrated healthcare and pharmacy solutions provider, released its fourth-quarter 2024 earnings on February 12, 2025.
CVS Health (CVS) Q4 2024 Earnings Call Transcript
CVS Health (CVS) Q4 2024 Earnings Call Transcript
CVS Health (CVS) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for CVS Health (CVS) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
CVS Health Stock Up on Q4 Earnings & Revenue Beat, Margins Rise
CVS tops earnings and revenue estimates in the fourth quarter of 2024 amid macroeconomic impacts in the Health Care Benefits arm.
CVS Health (CVS) Tops Q4 Earnings and Revenue Estimates
CVS Health (CVS) came out with quarterly earnings of $1.19 per share, beating the Zacks Consensus Estimate of $0.89 per share. This compares to earnings of $2.12 per share a year ago.
CVS Health Q4 Earnings: Revenue And EPS Beat, Same-store Prescription Volume Up 5.9%, Upbeat FY25 Outlook And More
On Wednesday, CVS Health Corp CVS reported fourth-quarter sales of $97.71 billion, beating the consensus of $97.19 billion.
CVS Health beats quarterly profit estimates on lower medical costs
CVS Health reported a smaller-than-expected drop in fourth-quarter profit on Wednesday as the pace of medical cost increases slowed at the healthcare conglomerate and revenues jumped in its pharmacy business, sending its shares up more than 9% in premarket trading.
